169 related articles for article (PubMed ID: 37128318)
1. Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
Feser R; Opperman RM; Nault B; Maiti S; Chen VC; Majumder M
Heliyon; 2023 Apr; 9(4):e15421. PubMed ID: 37128318
[TBL] [Abstract][Full Text] [Related]
2. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
[TBL] [Abstract][Full Text] [Related]
3. Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer.
Majumder M; Ugwuagbo KC; Maiti S; Lala PK; Brackstone M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359739
[TBL] [Abstract][Full Text] [Related]
4. Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer.
Hunter S; Nault B; Ugwuagbo KC; Maiti S; Majumder M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277414
[TBL] [Abstract][Full Text] [Related]
5. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
[TBL] [Abstract][Full Text] [Related]
6. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Potential of MiR-379/656 MicroRNA Cluster in Molecular Subtypes of Breast Cancer.
Lal M; Ansari AH; Agrawal A; Mukhopadhyay A
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575183
[TBL] [Abstract][Full Text] [Related]
10. Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.
Bailey ST; Westerling T; Brown M
Cancer Res; 2015 Jan; 75(2):436-45. PubMed ID: 25388283
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.
Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
Am J Cancer Res; 2022; 12(4):1784-1823. PubMed ID: 35530281
[TBL] [Abstract][Full Text] [Related]
14. Expression of micrornas in molecular genetic breast cancer subtypes.
Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
[TBL] [Abstract][Full Text] [Related]
15. Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer.
Kim MW; Park S; Lee H; Gwak H; Hyun KA; Kim JY; Jung HI; Il Kim S
Cancer Sci; 2021 Dec; 112(12):5078-5087. PubMed ID: 34626053
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
17. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway.
Wang Q; Lv L; Li Y; Ji H
Mol Med Rep; 2018 Sep; 18(3):3106-3114. PubMed ID: 30015840
[TBL] [Abstract][Full Text] [Related]
19. Integrating microRNA expression, miRNA-mRNA regulation network and signal pathway: a novel strategy for lung cancer biomarker discovery.
Nie R; Niu W; Tang T; Zhang J; Zhang X
PeerJ; 2021; 9():e12369. PubMed ID: 34754623
[TBL] [Abstract][Full Text] [Related]
20. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
